Glykit-M 1 Tablet SR
Marketer
Forschung India
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Glykit-M 1 Tablet SR
Diabex Duo 1mg SR tablets are classified as antidiabetic medications. This dual-action formulation manages type 2 diabetes in adults by regulating blood glucose. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Maintain regular mealtimes and carry a fast-acting glucose source (e.g., sugary snacks, fruit juice) to mitigate this risk. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. Diabex Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.
Primary Ingredients of Glykit-M 1 Tablet SR
No text was provided to rewrite.
Uses of Glykit-M 1 Tablet SR
Managing type 2 diabetes
Major Benefits of Glykit-M 1 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take one Glykit-M 1 SR tablet with a meal.
Common Side effects of Glykit-M 1 Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glykit-M 1 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Glykit-M 1 Tablet SR. Ingest the tablet whole; do not crush, chew, or fracture it. Administer this medication with food.
How Glykit-M 1 Tablet SR works:
Glykit-M SR, a single-tablet formulation, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and improving insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Glykit-M 1 Tablet SR ingestion is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glykit-M 1 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is recommended.
Breast feedingUNSAFE
Sustained-release Glykit-M tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.
DrivingCAUTION
Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with impaired kidney function should use Glykit-M 1 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician before taking this medication. Regular monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glykit-M 1 Tablet SR cautiously, potentially requiring dose modification. Consultation with a physician is advised. In those with mild to moderate hepatic dysfunction, Glykit-M 1 Tablet SR initiation should begin with a low dosage; however, it's contraindicated in patients with severe liver disease.
What if you forget to take Glykit-M 1 Tablet SR :
Should you forget to take your Glykit-M 1 Tablet SR, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Glykit-M 1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |


